After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
AMGEN Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of AMGEN Inc is $160.37B. A total of 2.52 million shares were traded on the day, compared to an average of 2.22M shares.
In the most recent transaction, Grygiel Nancy A. sold 1,267 shares of AMGN for 296.99 per share on Aug 20 ’25. After the transaction, the SVP & CCO now owns 7,209 company shares. In a previous transaction on Aug 20 ’25, Grygiel Nancy A. bought 1,267 shares at 294.32 per share.
Among the insiders who sold shares, Khosla Rachna disposed of 1,500 shares on Jun 05 ’25 at a per-share price of $289.68. This resulted in the SVP, Business Development holding 8,162 shares of AMGN after the transaction. In another insider transaction, Khosla Rachna bought 1,500 shares at $290.00 per share on Jun 05 ’25.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. AMGEN Inc pays an annual dividend of $9.39, resulting in a dividend yield of 3.15%, and it has a price to earnings (P/E) ratio of 24.37.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, AMGN has a high of $335.88 and a low of $253.30.
As of this writing, AMGN has an earnings estimate of $5.02 per share for the current quarter. EPS was calculated based on a consensus of 24.0 estimates, with a high estimate of $5.46 per share and a lower estimate of $4.2. The company reported an EPS of $5.58 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AMGN’s latest balance sheet shows that the firm has $8.04B in Cash & Short Term Investments as of fiscal 2021. There were $33.31B in debt and $12.18B in liabilities at the time. Its Book Value Per Share was $13.80, while its Total Shareholder’s Equity was $6.70B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMGN is Buy with a score of 3.64.
